Oliver Lagore Vanvalin Investment Group Heart Test Laboratories, Inc. Transaction History

Oliver Lagore Vanvalin Investment Group

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.11 - $0.18 $1,567 - $2,565	-14,250 Reduced 16.84%	70,358 $8,000
Q4 2023 Jan 31, 2024	BUY	$0.15 - $0.43 $2,250 - $6,450	15,001 Added 21.55%	84,608 $14,000
Q3 2023 Nov 09, 2023	SELL	$0.38 - $0.98 $16,433 - $42,382	-43,247 Reduced 38.32%	69,607 $29,000
Q2 2023 Aug 08, 2023	SELL	$0.83 - $1.26 $36,334 - $55,157	-43,776 Reduced 27.95%	112,854 $101,000
Q1 2023 Jun 20, 2023	SELL	$0.78 - $3.4 $4,066 - $17,727	-5,214 Reduced 3.22%	156,630 $155,000
Q4 2022 Mar 02, 2023	BUY	$0.8 - $267.0 $109,475 - $36.5 Million	136,844 Added 547.38%	161,844 $135,000
Q3 2022 Nov 15, 2022	BUY	$1.15 - $126.0 $28,749 - $3.15 Million	25,000 New	25,000 $30,000

Ticker HSCS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,202,550
Market Cap $23.8M
Description
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urg...

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.